On October 11, 2018, the United States Patent and Trademark Office (USPTO) announced a change in the claim construction standard used for...
PGR
-
-
Since the Federal Circuit’s October 5, 2017 decision in Amgen Inc. v. Sanofi overruling the so-called “newly characterized antigen”...
-
Posted in:
USPTO Trims the Regulatory Fat
On Friday, January 19, 2018, in a Federal Register notice, the USPTO identified four regulations that it is proposing to abolish. The...
-
Post-grant review (PGR) is the least common post-issuance trial proceeding before the Patent Trial and Appeal Board (PTAB). Only 1% of...
-
In an effort to combat pharmaceutical patent holders, several companies are now filing petitions for post-grant review on the theory that...
-
In Cox Communications, Inc. v. Sprint Communication Co. LP, No. 2016-1013 (Fed. Cir. Sept. 23, 2016), the Federal Circuit reversed the...
-
The PTAB has been reluctant to find that an unnamed party is a real party-in-interest in an AIA review or in privity with the named...
-
The America Invents Act (AIA) of 2011 ushered in a new era for the Court of Appeals for the Federal Circuit, introducing 3 new post-grant...